• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

细胞因子风暴引发的应激性心肌病中嘌呤能系统的当前药理学与调节

Current Pharmacology and Modulation of the Purinergic System in Takotsubo Syndrome Triggered by Cytokine Storm.

作者信息

Simões Júlia Leão Batista, Braga Geórgia de Carvalho, Mittelmann Tamíres Hillesheim, Bagatini Margarete Dulce

机构信息

Medical School, Federal University of Fronteira Sul, Chapecó, SC, Brazil.

Graduate Program in Medical Sciences, Federal University of Fronteira Sul, Chapecó, SC, Brazil.

出版信息

Curr Probl Cardiol. 2024 Jan;49(1 Pt A):102019. doi: 10.1016/j.cpcardiol.2023.102019. Epub 2023 Aug 5.

DOI:10.1016/j.cpcardiol.2023.102019
PMID:37544631
Abstract

Studies show that with the COVID-19 pandemic, the world's population went through multiple stress and anxiety factors, generating serious psychological problems, in addition, the virus also caused damage and physical stress to those contaminated. In this way, the intense emotional experiences and stressful effects on the body caused by SARS-CoV-2 are capable of triggering the excessive release of catecholamines in the body. Thus, the framework of Takotsubo Syndrome is characterized by myocardial dysfunction as a response of cardiac receptors to the spillage of such hormones in an unregulated way in the human body. The purinergic system plays a central role in this process, as it actively participates in actions responsible for the syndromic cascade, such as the stress generated by the cytokine storm triggered by the virus and the stimulation of deregulated catecholamine release. Therefore, further pharmacological studies on the role of purines in this pathology should be developed in order to avoid the evolution of the syndrome and to modulate its P1 and P2 receptors aiming at developing means of reversing or treating the Takotsubo Syndrome.

摘要

研究表明,在新冠疫情期间,世界人口经历了多种压力和焦虑因素,引发了严重的心理问题,此外,该病毒还对感染者造成了损害和身体压力。这样一来,由严重急性呼吸综合征冠状病毒2(SARS-CoV-2)引起的强烈情感体验和对身体的压力效应能够触发体内儿茶酚胺的过度释放。因此,应激性心肌病的发病机制以心肌功能障碍为特征,这是心脏受体对这类激素在人体内无节制溢出的一种反应。嘌呤能系统在这一过程中起着核心作用,因为它积极参与导致该综合征一系列反应的活动,如病毒引发的细胞因子风暴所产生的压力以及对失控的儿茶酚胺释放的刺激。因此,应进一步开展关于嘌呤在这种病理状态中作用的药理学研究,以避免该综合征的进展,并调节其P1和P2受体,旨在开发出逆转或治疗应激性心肌病的方法。

相似文献

1
Current Pharmacology and Modulation of the Purinergic System in Takotsubo Syndrome Triggered by Cytokine Storm.细胞因子风暴引发的应激性心肌病中嘌呤能系统的当前药理学与调节
Curr Probl Cardiol. 2024 Jan;49(1 Pt A):102019. doi: 10.1016/j.cpcardiol.2023.102019. Epub 2023 Aug 5.
2
Correlation between takotsubo cardiomyopathy and SARS-CoV-2 infection.心肌梗死后心肌病与 SARS-CoV-2 感染的相关性。
Med Hypotheses. 2021 Jan;146:110454. doi: 10.1016/j.mehy.2020.110454. Epub 2020 Dec 9.
3
Takotsubo Syndrome and COVID-19: Associations and Implications.心尖球形综合征与 COVID-19:关联与意义。
Curr Probl Cardiol. 2021 Mar;46(3):100763. doi: 10.1016/j.cpcardiol.2020.100763. Epub 2020 Dec 11.
4
Takotsubo cardiomyopathy caused by emotional stressors in the coronavirus disease 2019 (COVID-19) pandemic era.在 2019 冠状病毒病(COVID-19)大流行时期,情绪应激导致的心肌顿抑综合征。
J Card Surg. 2021 Feb;36(2):764-769. doi: 10.1111/jocs.15251. Epub 2020 Dec 18.
5
Takotsubo cardiomyopathy triggered by SARS-CoV-2 infection in a critically ill patient.一名危重症患者中由新型冠状病毒2型(SARS-CoV-2)感染引发的应激性心肌病。
BMJ Case Rep. 2020 Jun 14;13(6):e236561. doi: 10.1136/bcr-2020-236561.
6
Update of takotsubo syndrome in the era of COVID-19.COVID-19 时代的应激性心肌病更新。
J Cardiol. 2021 Apr;77(4):361-369. doi: 10.1016/j.jjcc.2020.10.004. Epub 2020 Oct 14.
7
Takotsubo syndrome in COVID-19: a case series study.新型冠状病毒肺炎相关性心肌顿抑综合征:病例系列研究。
Echocardiography. 2022 Jul;39(7):920-934. doi: 10.1111/echo.15398. Epub 2022 Jun 22.
8
Takotsubo syndrome as an outcome of the use of checkpoint inhibitor therapy in patients with COVID-19.COVID-19 患者使用免疫检查点抑制剂治疗后的 Takotsubo 综合征。
Biochem Pharmacol. 2024 Aug;226:116388. doi: 10.1016/j.bcp.2024.116388. Epub 2024 Jun 22.
9
Therapeutic Potential of P2X7 Purinergic Receptor Modulation in the Main Organs Affected by the COVID-19 Cytokine Storm.P2X7 嘌呤能受体调节在 COVID-19 细胞因子风暴影响的主要器官中的治疗潜力。
Curr Pharm Des. 2022;28(22):1798-1814. doi: 10.2174/1381612828666220713115906.
10
A review of the presentation and outcome of takotsubo cardiomyopathy in COVID-19.综述 COVID-19 中应激性心肌病的临床表现和转归。
Monaldi Arch Chest Dis. 2021 Mar 23;91(3). doi: 10.4081/monaldi.2021.1710.